New cancer chemotherapeutic agents
- 1 December 1972
- Vol. 30 (6), 1639-1646
- https://doi.org/10.1002/1097-0142(197212)30:6<1639::aid-cncr2820300633>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanomaEuropean Journal of Cancer (1965), 1972
- Immunosuppressive, antiviral and antitumor activities of cytarabine derivativesBiochemical Pharmacology, 1972
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Streptozotocin and Metastatic InsulinomaAnnals of Internal Medicine, 1971
- Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumorsCancer, 1970
- Experimental Studies with L-Asparaginase in Mouse LeukemiasPublished by Springer Nature ,1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969
- Preliminary Clinical Assessment of I.C.R.F. 159 in Acute Leukaemia and LymphosarcomaBMJ, 1969
- Nucleic acids components and their analogues. LI. Synthesis of 1-glycosyl derivatives of 5-azauracil and 5-azacytosineCollection of Czechoslovak Chemical Communications, 1964
- Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma EffectsNature, 1961